Sign In
Buy LEGN
$35.98
-0.300 (-0.83%)
At Close: Jun 03, 2026
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
08:00am, Tuesday, 28'th Apr 2026
SOMERSET, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET
Legend Biotech: Undervalued Leader In The CAR-T Race
10:04am, Friday, 24'th Apr 2026
In my opinion, Legend Biotech Corporation is an attractive acquisition target for Johnson & Johnson. Carvykti, which they are jointly developing, is quickly catching up in sales with Darzalex, J&J's b
Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last?
10:57am, Tuesday, 21'st Apr 2026
Legend Biotech (LEGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near te
Why Legend Biotech Stock Crushed the Market on Monday
06:16pm, Monday, 20'th Apr 2026
This followed a sizable acquisition of a peer biotech by a pharmaceutical sector giant. Legend has innovative science backing its oncology drug development efforts.
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of “Moderate Buy” by Brokerages
04:59am, Saturday, 04'th Apr 2026
Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fifteen research firms that are presently covering the company,
ArrowMark Colorado Holdings LLC Has $30.61 Million Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN
04:24am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC lowered its holdings in Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN) by 4.6% during the third quarter, according to its most recent filing with the Securitie
Capital International Investors Sells 140,873 Shares of Legend Biotech Corporation Sponsored ADR $LEGN
04:08am, Friday, 13'th Mar 2026
Capital International Investors decreased its stake in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN) by 13.0% in the third quarter, according to the company in its most recent Form
Legend Biotech Corporation (LEGN) Q4 2025 Earnings Call Transcript
01:00pm, Tuesday, 10'th Mar 2026
Legend Biotech Corporation (LEGN) Q4 2025 Earnings Call Transcript
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
07:00am, Tuesday, 10'th Mar 2026
SOMERSET, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported financial results for the fourth quarter
Artisan International Small-Mid Fund Q4 2025 Performance Review
01:38pm, Monday, 02'nd Mar 2026
The portfolio meaningfully outperformed the MSCI EAFE Small Cap Growth Index but modestly lagged the blend MSCI ACWI ex USA SMID Index. Our portfolio, which has a structural growth orientation, has no
Artisan Partners Limited Partnership Purchases 425,684 Shares of Legend Biotech Corporation Sponsored ADR $LEGN
04:25am, Saturday, 28'th Feb 2026
Artisan Partners Limited Partnership increased its position in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN) by 20.1% during the undefined quarter, according to its most recent fil
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
10:30pm, Thursday, 29'th Jan 2026
From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems' ability
Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on Wednesday, after the worst day for stocks since October. Stocks w
Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
01:46pm, Wednesday, 14'th Jan 2026
Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Connective Portfolio Management LLC Acquires New Holdings in Legend Biotech Corporation Sponsored ADR $LEGN
05:03am, Saturday, 27'th Dec 2025
Connective Portfolio Management LLC bought a new stake in Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN) in the undefined quarter, according to the company in its most recent disclosure with
